HLB Life Science Co., Ltd.

KOSDAQ:A067630 Stok Raporu

Piyasa değeri: ₩1.0t

HLB Life Science Gelecekteki Büyüme

Future kriter kontrolleri 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for HLB Life Science.

Anahtar bilgiler

n/a

Kazanç büyüme oranı

n/a

EPS büyüme oranı

Healthcare kazanç büyümesi18.8%
Gelir büyüme oranın/a
Gelecekteki özkaynak getirisin/a
Analist kapsamı

None

Son güncellemen/a

Gelecekteki son büyüme güncellemeleri

Güncelleme yok

Recent updates

HLB Life Science Co., Ltd.'s (KOSDAQ:067630) Popularity With Investors Under Threat As Stock Sinks 26%

Oct 24
HLB Life Science Co., Ltd.'s (KOSDAQ:067630) Popularity With Investors Under Threat As Stock Sinks 26%

What HLB Life Science Co., Ltd.'s (KOSDAQ:067630) P/S Is Not Telling You

Aug 30
What HLB Life Science Co., Ltd.'s (KOSDAQ:067630) P/S Is Not Telling You

HLB Life Science (KOSDAQ:067630) Shareholders Should Be Cautious Despite Solid Earnings

May 21
HLB Life Science (KOSDAQ:067630) Shareholders Should Be Cautious Despite Solid Earnings

HLB Life Science Co., Ltd.'s (KOSDAQ:067630) 25% Share Price Surge Not Quite Adding Up

Mar 15
HLB Life Science Co., Ltd.'s (KOSDAQ:067630) 25% Share Price Surge Not Quite Adding Up

HLB Life Science (KOSDAQ:067630) Has Debt But No Earnings; Should You Worry?

Apr 12
HLB Life Science (KOSDAQ:067630) Has Debt But No Earnings; Should You Worry?

Did You Participate In Any Of HLB Life Science's (KOSDAQ:067630) Incredible 442% Return?

Feb 14
Did You Participate In Any Of HLB Life Science's (KOSDAQ:067630) Incredible 442% Return?

Is HLB Life Science (KOSDAQ:067630) A Risky Investment?

Jan 10
Is HLB Life Science (KOSDAQ:067630) A Risky Investment?

We're Not So Sure You Should Rely on HLB Life Science's (KOSDAQ:067630) Statutory Earnings

Dec 06
We're Not So Sure You Should Rely on HLB Life Science's (KOSDAQ:067630) Statutory Earnings

Bu bölümde, yatırımcıların şirketin kâr elde etme kabiliyetini anlamalarına yardımcı olmak için genellikle profesyonel analistlerin fikir birliği tahminlerine dayanan gelir ve kazanç büyüme tahminlerini sunuyoruz. Ancak HLB Life Science yeterli geçmiş veri sağlamadığından ve analist tahmini olmadığından, gelecekteki kazançları geçmiş verileri ekstrapole ederek veya analist tahminlerini kullanarak güvenilir bir şekilde hesaplanamaz.

SimplyWall St tarafından kapsanan şirketlerin %97'si geçmiş finansal verilere sahip olduğu için bu oldukça nadir bir durumdur.

Kazanç ve Gelir Büyüme Tahminleri

KOSDAQ:A067630 - Analistlerin gelecek tahminleri ve geçmiş finansal verileri (KRW Millions )
TarihGelirKazançlarSerbest Nakit AkışıFaaliyetlerden NakitAvg. Analist Sayısı
6/30/202492,870-9,205-56,513-28,104N/A
3/31/202490,719125,455-40,486-19,030N/A
12/31/202397,990-5,983-30,307-10,016N/A
9/30/2023101,918-74,410-33,738-16,955N/A
6/30/2023120,360-46,626-45,357-27,667N/A
3/31/2023114,798-30,251-39,689-25,050N/A
12/31/202299,591-54,277-41,464-29,744N/A
9/30/202287,628-56,700-29,388-23,049N/A
6/30/202261,067-20,834-24,214-23,292N/A
3/31/202258,848-44,045-20,250-18,750N/A
12/31/202153,494-49,152-16,551-14,084N/A
9/30/202157,296-28,397-11,657-192N/A
6/30/202162,917-63,998-6,8205,398N/A
3/31/202170,598-45,888-9,8913,481N/A
12/31/202091,797-55,797-18,7982,010N/A
9/30/2020102,4273,809-22,5721,791N/A
6/30/2020112,471-20,064-33,216-9,267N/A
3/31/2020118,918-26,267-35,354-11,191N/A
12/31/2019114,019-7,605-30,736-12,388N/A
9/30/2019111,639-43,329-30,779-25,225N/A
6/30/2019107,874-31,166-22,418-8,178N/A
3/31/2019105,435-23,689-21,994-8,617N/A
12/31/2018102,476-18,191-21,610-11,073N/A
9/30/2018105,0409,936-20,373-9,872N/A
6/30/2018103,6439,613-4,297-2,897N/A
3/31/2018106,9306,681N/A872N/A
12/31/2017106,4457,761N/A-302N/A
9/30/2017108,191564N/A7,454N/A
6/30/201784,642-906N/A1,719N/A
3/31/201759,517-1,174N/A-2,046N/A
12/31/201642,234-1,251N/A-2,273N/A
9/30/201620,970-8,003N/A-3,700N/A
6/30/201625,730-8,880N/A-3,370N/A
3/31/201629,191-15,904N/A-4,576N/A
12/31/201527,323-17,041N/A-4,341N/A
9/30/201529,034-10,493N/A-7,709N/A
6/30/201534,740-7,677N/A-3,142N/A
3/31/201536,58044N/A9,143N/A
12/31/201436,5601,331N/A10,432N/A
9/30/201426,921-1,595N/A8,693N/A
6/30/201427,651-2,417N/A10,009N/A
3/31/201422,631-3,968N/A2,333N/A
12/31/201319,956-4,446N/A2,949N/A

Analist Gelecek Büyüme Tahminleri

Kazançlar ve Tasarruf Oranları: Insufficient data to determine if A067630's forecast earnings growth is above the savings rate (2.6%).

Kazançlar ve Piyasa: Insufficient data to determine if A067630's earnings are forecast to grow faster than the KR market

Yüksek Büyüme Kazançları: Insufficient data to determine if A067630's earnings are expected to grow significantly over the next 3 years.

Gelir ve Pazar: Insufficient data to determine if A067630's revenue is forecast to grow faster than the KR market.

Yüksek Büyüme Geliri: Insufficient data to determine if A067630's revenue is forecast to grow faster than 20% per year.


Hisse Başına Kazanç Büyüme Tahminleri


Gelecekteki Özkaynak Getirisi

Gelecekteki ROE: Insufficient data to determine if A067630's Return on Equity is forecast to be high in 3 years time


Büyüyen şirketleri keşfedin